Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription


1 Ann Intern Med
3 Antimicrob Agents Chemother
2 Antiviral Res
3 Arch Virol
1 Biochem Biophys Res Commun
13 BMJ
3 Cell
1 Drug Saf
1 Epidemiol Infect
1 J Exp Med
2 J Infect
3 J Virol
16 Lancet
2 Lancet Infect Dis
1 Lancet Public Health
1 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
5 PLoS One
2 Proc Natl Acad Sci U S A
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

    Adding oseltamivir to usual primary care reduced recovery time in influenza-like illness.
    Ann Intern Med. 2020;172:JC43.

    Antimicrob Agents Chemother

  2. KOSHIMICHI H, Retout S, Cosson V, Duval V, et al
    Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Patients Infected with Influenza at High Risk of Influenza Complications.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00119.
    PubMed         Abstract available

    Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.00399.
    PubMed         Abstract available

  4. ZHAO L, Yan Y, Dai Q, Li X, et al
    Development of Novel Anti-influenza Thiazolides with Relatively Broad-spectrum Antiviral Potentials.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00222.
    PubMed         Abstract available

    Antiviral Res

  5. TOURET F, de Lamballerie X
    Of chloroquine and COVID-19.
    Antiviral Res. 2020;177:104762.
    PubMed         Abstract available

  6. SIGRIST C, Bridge A, Le Mercier P
    A potential role for integrins in host cell entry by SARS-CoV-2.
    Antiviral Res. 2020 Mar 1:104759. doi: 10.1016/j.antiviral.2020.104759.

    Arch Virol

  7. LI H, Cao L, Zhang Y, Ren H, et al
    Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice.
    Arch Virol. 2020;165:1057-1067.
    PubMed         Abstract available

  8. YUN KW, Choi EH, Lee HJ
    Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons (1990-2018) and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea.
    Arch Virol. 2020;165:1069-1077.
    PubMed         Abstract available

  9. ARBI M, Souiai O, Rego N, Larbi I, et al
    Historical origins and zoonotic potential of avian influenza virus H9N2 in Tunisia revealed by Bayesian analysis and molecular characterization.
    Arch Virol. 2020 Apr 25. pii: 10.1007/s00705-020-04624.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  10. HUANG Q, Zhong Y, Li J, Ye Y, et al
    Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication.
    Biochem Biophys Res Commun. 2020 Apr 13. pii: S0006-291X(20)30756.
    PubMed         Abstract available


  11. Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines.
    BMJ. 2020;369:m1461.

  12. YARDLEY S, Rolph M
    Death and dying during the pandemic.
    BMJ. 2020;369:m1472.

  13. MCKEE M
    A European roadmap out of the covid-19 pandemic.
    BMJ. 2020;369:m1556.

    Keep older healthcare workers off the covid-19 front line.
    BMJ. 2020;369:m1511.

  15. VETTER P, Vu DL, L'Huillier AG, Schibler M, et al
    Clinical features of covid-19.
    BMJ. 2020;369:m1470.

    PPE guidance for covid-19: be honest about resource shortages.
    BMJ. 2020;369:m1507.

  17. MUIR G, Boff J
    Covid-19: "Steady the front line! There is no retreat from here".
    BMJ. 2020;369:m1540.

  18. SIMPSON PL, Butler TG
    Covid-19, prison crowding, and release policies.
    BMJ. 2020;369:m1551.

  19. MAWER C
    Covid-19: We need to be open about rationing ventilators.
    BMJ. 2020;369:m1542.

  20. KHUNTI K, Singh AK, Pareek M, Hanif W, et al
    Is ethnicity linked to incidence or outcomes of covid-19?
    BMJ. 2020;369:m1548.

  21. LUCE T
    Covid 19: death certification in England and Wales.
    BMJ. 2020;369:m1571.

  22. ZHENG S, Fan J, Yu F, Feng B, et al
    Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
    BMJ. 2020;369:m1443.
    PubMed         Abstract available

  23. ARCHARD D, Caplan A
    Is it wrong to prioritise younger patients with covid-19?
    BMJ. 2020;369:m1509.


  24. HOFFMANN M, Kleine-Weber H, Schroeder S, Kruger N, et al
    SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Cell. 2020;181:271-280.
    PubMed         Abstract available

  25. ZHANG YZ, Holmes EC
    A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.
    Cell. 2020;181:223-227.
    PubMed         Abstract available

  26. COVID-19: Navigating Uncertainties Together.
    Cell. 2020;181:209-210.

    Drug Saf

  27. MOORE N
    Chloroquine for COVID-19 Infection.
    Drug Saf. 2020;43:393-394.

    Epidemiol Infect

    The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020.
    Epidemiol Infect. 2020;148:e82.
    PubMed         Abstract available

    J Exp Med

  29. BARNES BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, et al
    Targeting potential drivers of COVID-19: Neutrophil extracellular traps.
    J Exp Med. 2020;217.
    PubMed         Abstract available

    J Infect

  30. CHEN J, Qi T, Liu L, Ling Y, et al
    Clinical progression of patients with COVID-19 in Shanghai, China.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30119.
    PubMed         Abstract available

  31. IBRAHIM IM, Abdelmalek DH, Elshahat ME, Elfiky AA, et al
    COVID-19 spike-host cell receptor GRP78 binding site prediction.
    J Infect. 2020 Mar 10. pii: S0163-4453(20)30107.
    PubMed         Abstract available

    J Virol

  32. RAHIM MMA, Parsons BD, Price EL, Slaine PD, et al
    Defective influenza A virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins.
    J Virol. 2020 Apr 22. pii: JVI.00165-20. doi: 10.1128/JVI.00165.
    PubMed         Abstract available

  33. VERHAGEN JH, Poen M, Stallknecht DE, van der Vliet S, et al
    Phylogeography and antigenic diversity of low pathogenic avian influenza H13 and H16 viruses.
    J Virol. 2020 Apr 22. pii: JVI.00537-20. doi: 10.1128/JVI.00537.
    PubMed         Abstract available

  34. EGGINK D, Spronken M, van der Woude R, Buzink J, et al
    Phenotypic effects of substitutions within the receptor binding site of highly pathogenic avian influenza H5N1 observed during human infection.
    J Virol. 2020 Apr 22. pii: JVI.00195-20. doi: 10.1128/JVI.00195.
    PubMed         Abstract available


  35. ABBASI J
    FLU-v, a Universal Flu Vaccine Candidate, Advances in Trial.
    JAMA. 2020;323:1336.


  36. HOPE MD, Raptis CA, Shah A, Hammer MM, et al
    A role for CT in COVID-19? What data really tell us so far.
    Lancet. 2020 Mar 27. pii: S0140-6736(20)30728.

  37. MITJA O, Arenas A, Rodo X, Tobias A, et al
    Experts' request to the Spanish Government: move Spain towards complete lockdown.
    Lancet. 2020;395:1193-1194.

    COVID-19 gives the lie to global health expertise.
    Lancet. 2020 Mar 26. pii: S0140-6736(20)30739.

  39. CHOW R
    A citizen's thoughts about COVID-19.
    Lancet. 2020 Mar 26. pii: S0140-6736(20)30692.

  40. CLUVER L, Lachman JM, Sherr L, Wessels I, et al
    Parenting in a time of COVID-19.
    Lancet. 2020;395:e64.

  41. HAINES A, de Barros EF, Berlin A, Heymann DL, et al
    National UK programme of community health workers for COVID-19 response.
    Lancet. 2020;395:1173-1175.

  42. REMUZZI A, Remuzzi G
    COVID-19 and Italy: what next?
    Lancet. 2020 Mar 13. pii: S0140-6736(20)30627.
    PubMed         Abstract available

  43. WANG H, Li T, Barbarino P, Gauthier S, et al
    Dementia care during COVID-19.
    Lancet. 2020 Mar 30. pii: S0140-6736(20)30755.

  44. DEVAKUMAR D, Shannon G, Bhopal SS, Abubakar I, et al
    Racism and discrimination in COVID-19 responses.
    Lancet. 2020;395:1194.

  45. WATTS G
    Irene Higginson: progress towards a better ending.
    Lancet. 2020;395:1183.

  46. YUAN S
    Tsinghua University launches School of Public Health.
    Lancet. 2020;395:1182.

    Virtual health care in the era of COVID-19.
    Lancet. 2020;395:1180-1181.

  48. JAFFE S
    Regulators split on antimalarials for COVID-19.
    Lancet. 2020;395:1179.

  49. HALL KS, Samari G, Garbers S, Casey SE, et al
    Centring sexual and reproductive health and justice in the global COVID-19 response.
    Lancet. 2020;395:1175-1177.

    The gendered dimensions of COVID-19.
    Lancet. 2020;395:1168.

    Palliative care and the COVID-19 pandemic.
    Lancet. 2020;395:1168.

    Lancet Infect Dis

  52. LEE EYP, Ng MY, Khong PL
    COVID-19 pneumonia: what has CT taught us?
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30134.

  53. CHEN X, Tian J, Li G, Li G, et al
    Initiation of a new infection control system for the COVID-19 outbreak.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30110.

    Lancet Public Health

  54. COWLING BJ, Ali ST, Ng TWY, Tsang TK, et al
    Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.
    Lancet Public Health. 2020 Apr 17. pii: S2468-2667(20)30090.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  55. CHANG A, Schnall AH, Law R, Bronstein AC, et al
    Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 - National Poison Data System, United States, January 1, 2020-March 31, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:496-498.
    PubMed         Abstract available

    N Engl J Med

  56. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Caring for Patients with Covid-19.
    N Engl J Med. 2020;382:e50.

  57. VAN DOREMALEN N, Bushmaker T, Morris DH, Holbrook MG, et al
    Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.
    N Engl J Med. 2020 Mar 17. doi: 10.1056/NEJMc2004973.

  58. BRANDT AM, Botelho A
    Not a Perfect Storm - Covid-19 and the Importance of Language.
    N Engl J Med. 2020;382:1493-1495.

    PLoS One

  59. LI M, Chen L, Zhang J, Xiong C, et al
    The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study.
    PLoS One. 2020;15:e0230295.
    PubMed         Abstract available

  60. CHOWDHURY F, Shahid ASMSB, Ghosh PK, Rahman M, et al
    Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh.
    PLoS One. 2020;15:e0228329.
    PubMed         Abstract available

  61. GAO J, Zheng P, Jia Y, Chen H, et al
    Mental health problems and social media exposure during COVID-19 outbreak.
    PLoS One. 2020;15:e0231924.
    PubMed         Abstract available

  62. WHITMAN J, Jayaprakash C
    Stochastic modeling of influenza spread dynamics with recurrences.
    PLoS One. 2020;15:e0231521.
    PubMed         Abstract available

  63. MCFADDEN SM, Malik AA, Aguolu OG, Willebrand KS, et al
    Perceptions of the adult US population regarding the novel coronavirus outbreak.
    PLoS One. 2020;15:e0231808.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  64. MOGHADAS SM, Shoukat A, Fitzpatrick MC, Wells CR, et al
    Projecting hospital utilization during the COVID-19 outbreaks in the United States.
    Proc Natl Acad Sci U S A. 2020;117:9122-9126.
    PubMed         Abstract available

    News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 2005456117.


  66. WOODS PS, Doolittle LM, Rosas LE, Nana-Sinkam SP, et al
    Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.
    Virology. 2020;545:40-52.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.